Positron moves manufacturing facility

Positron, a molecular imaging company specializing in nuclear cardiology, has relocated its PosiRx manufacturing, product research and development facility. The new office is approximately three miles from its current Fishers, Ind., location.

The facility, approximately 10,000 square feet, provides space for Positron’s engineering development, equipment manufacturing and research departments. The new facility enables Positron to consolidate two existing central Indiana sites at one campus.

The new location also will serve as an interim headquarters facility for Positron's future cyclotron project in the neighboring city of Noblesville. This move will not impact Positron’s current radiopharmaceutical manufacturing facility in Crown Point, Ind., according to the company.

The new location will also serve as a PosiRx product showcase and training facility for clients and potential customers.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.